DEFB1 (Gene)

Organism:

Homo sapiens

Synonyms:BD1, DEFB-1, DEFB1, DEFB101, ENTREZ:1672, HBD1, HGNC:2766, MIM:602056, NM_005218, NP_005209, defensin beta 1

Omim:OMIM:602056

Id:4e1b96c0-afe7-5cd1-baf4-82fc2102702f

Hgnc:HGNC:2766

Entrez:1672

Ensembl:ENSG00000164825

Description:defensin beta 1

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View DEFB1's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with DEFB1.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using DEFB1.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for DEFB1.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with DEFB1.

Results found

Linked to

	Label	Description
	GSE150895 GSE150896 enzalutamide 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 13 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE142210 2 V 5 PANOBINOSTAT HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE242333 sorafenib 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE199204,GSE211619 4 V 3 GLUTAMINE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE115542 digoxin 5 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434,GSE202438 13 V 5 TALAZOPARIB HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE234148 HDAC inhibition 3 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE150895,GSE150896 0 V 1 ENZALUTAMIDE HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE199107 tryptophan 0 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE150895 GSE150896 enzalutamide 0 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 13 v 5 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE142210 2 V 5 PANOBINOSTAT HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE242333 sorafenib 0 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE199204,GSE211619 4 V 3 GLUTAMINE HUMAN DN

Gene Set (Entity type)

A Gene Set from LINCS

GSE115542 digoxin 5 v 3 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE202434,GSE202438 13 V 5 TALAZOPARIB HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE234148 HDAC inhibition 3 v 2 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE150895,GSE150896 0 V 1 ENZALUTAMIDE HUMAN UP

Gene Set (Entity type)

A Gene Set from LINCS

GSE199107 tryptophan 0 v 2 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.